Skip to main content
. Author manuscript; available in PMC: 2013 Jun 22.
Published in final edited form as: Int J Biostat. 2012 Jun 22;8(1):Article–15. doi: 10.1515/1557-4679.1233

Table 4.

Regression estimates

1 2 3 4 5 6 7 8 9
ALL vs AML .07 (.25) 1.32 (.36) .50 (.23) .45 (.38) .12 (.30) .90 (.31) .58 (.22)
Age1 −.25 (.16) −.68 (.28) −.49 (.32) −.45 (.26)
Age2 .27 (.20) .33 (.23) .51 (.59) .01 (.24) .72 (.21)
FM −.20 (.28) −.57 (.39)
PBSCT vs BMT .09 (.22) .01 (.29) .28 (.30) −.12 (.66) −.17 (.38) .55 (.35)
ALLxPBSCT .46 (.23) .92 (.43)
AMLxPBSCT −.33 (.30)
AMLxBMT −.30 (.22) −.50 (.43)
DxCr .12 (.08) .45 (.16) .22 (.12) .13 (.14)
CrTx −.21 (.07) −.26 (.09) −.33 (.15) −.24 (.17) −.10 (.12)
prioir AGVHD .72 (.30) .72 (.20)
Age1xPBSCT −.44 (.34)
Age1xBMT −.57 (.33) .70 (.60) −.88 (.35) −.64 (.34)
Age2xPBSCT −.28 (.25) .13 (.37)
Age2xBMT −.37 (.24) .60 (.88)
Age0xPBSCT −.27 (.26) .40 (.31)
AMLxPBSCTxAge2 .25 (.22)
Age1xALL .61 (.27) −.87 (.48) −.60 (.42)
Age2xALL .57 (.30) −.97 (.47)
FMxALL .63 (.27)
FMxAML .64 (.17) .81 (.45)
FMxPBSCT .42 (.18) .44 (.25)
FXALL −.25 (.19)
FxAML −.19 (.14)

Columns: 1 = Tx → AGVHD; 2 = Tx → CGVHD; 3 = Tx → Relapse; 4 = Tx → Death 5 = AGVHD → CGVHD; 6 = AGVHD → Relapse; 7 = AGVHD → Death; 8 = CGVHD → Relapse; 9 = CGVHD → Death.

Variable names: Age0: age in the (29.5, 42, 5] range, Age1 = age ≤ 29.5 years, Age2 = age > 42.5 years; F = female donor transplant; FM = female donor to male recipient vs other sexmatch transplant.